The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2644 COVALENT BINDING OF 14 C 2-METHOXY-4-<br />
NITROANILINE IN MALE SPRAGUE-DAWLEY RATS.<br />
R. Snyder 1 , S. Waidyanatha 2 , I. Surh 2 , T. Banks 1 , P. Patel 1 , S. Black 1 and T.<br />
Fennell 1 . 1 RTI International, Research Triangle Park, NC and 2 National <strong>Toxicology</strong><br />
Program, National Institute <strong>of</strong> Environmental Health Sciences, Research Triangle<br />
Park, NC.<br />
2-Methoxy-4-nitroaniline (MNA) is used in dyeing textiles, as a dye in the printing<br />
industry, and as an intermediate in the synthesis <strong>of</strong> azo dyes that have applications<br />
in tattoo inks, emulsion paints, and toy enamels. MNA has structural similarity to<br />
the known carcinogens, 2-methoxy-5-nitroaniline (5-nitro-o-anisidine), o-anisidine<br />
and 2,4-diaminoanisole. <strong>The</strong> objective <strong>of</strong> this study was to evaluate the ability<br />
<strong>of</strong> MNA-derived metabolites to bind covalently to tissue macromolecules in<br />
rats. [Ring- 14 C] MNA was administered at 150 mg/kg b. wt. to male Sprague<br />
Dawley rats (approximately 220 μCi/rat) by gavage. After 24 h, animals were euthanized<br />
and blood and selected tissues were collected and analyzed for total radioactivity<br />
in tissues, radioactivity bound to tissues and to DNA. In tissues, the total radioactivity<br />
was highest in liver (0.31 ± 0.04 % <strong>of</strong> the dose) and kidney (0.053 ±<br />
0.021 %). However, the concentration <strong>of</strong> radioactivity was highest in kidney and<br />
cecum (91 ± 4 and 22 ± 1 μg equiv/g tissue, respectively). Concentrations were<br />
similar in ileum, jejunum, and large intestine (approximately 16 μg equiv/g).<br />
Radioactivity bound determined by exhaustive extraction was highest in liver (43%<br />
<strong>of</strong> the total in tissue) followed by kidney (13 % <strong>of</strong> the total in tissue), cecum (12 %)<br />
stomach (9 %), and large intestine (9 %). Binding was low in ileum, jejunum, and<br />
duodenum (1-2% bound). In red blood cells, 27% <strong>of</strong> the activity was bound compared<br />
with 3% in plasma. Radioactivity associated with DNA (pmol equiv/mg<br />
DNA) was highest in the cecum (160 ± 27 pmol/mg) followed by large intestine<br />
(13 ± 2 pmol/mg), and was not significantly above background in other tissues.<br />
<strong>The</strong>se studies suggest that MNA is metabolized to reactive species that are capable<br />
<strong>of</strong> binding to macromolecules including DNA. <strong>The</strong> nature <strong>of</strong> the metabolites <strong>of</strong><br />
MNA is under investigation in companion studies.<br />
2645 DIFFERENTIAL MODULATION OF CANCER-RELATED<br />
MOLECULAR NETWORKS IN HUMAN AND RAT<br />
URINARY BLADDER CELLS EXPOSED TO TRIVALENT<br />
ARSENICALS.<br />
K. Bailey 1 , K. Wallace 2 , S. Thai 2 , D. C. Wolf 2 , S. W. Edwards 2 and R. C. Fry 1 .<br />
1 Environmental Sciences and Engineering, University <strong>of</strong> North Carolina at Chapel<br />
Hill, Chapel Hill, NC and 2 U.S. EPA, Research Triangle Park, NC.<br />
Arsenic (As) is classified as a known human carcinogen with primary targets <strong>of</strong> urinary<br />
bladder (UB), skin and lung. <strong>The</strong> most prevalent source <strong>of</strong> As exposure in humans<br />
is drinking water contaminated with inorganic As (iAs). <strong>The</strong> mode <strong>of</strong> action<br />
(MOA) <strong>of</strong> As carcinogenesis in target cells is largely undefined, including which arsenical(s)<br />
elicit a carcinogenic response. Two urinary metabolites <strong>of</strong> iAs,<br />
monomethylarsonous acid and dimethylarsinous acid (MMAIII and DMAIII, respectively),<br />
are attractive candidates as UB carcinogens. We used a transcriptomics<br />
approach to examine the altered molecular pathways and networks in human and<br />
rat UB cells after exposure to individual arsenicals to investigate the MOA <strong>of</strong> Asdriven<br />
UB carcinogenesis. UROtsa (human) and MYP3 (rat) cells were exposed to<br />
relatively non-cytotoxic (>75% cell viability), environmentally-relevant concentrations<br />
(1 μM) <strong>of</strong> iAsIII, MMAIII, and DMAIII for 24 h. Differentially expressed<br />
genes were determined for each treatment group relative to controls and analyzed<br />
for statistically significant biological functions, molecular networks and canonical<br />
pathways. Each treatment group elicited a distinct transcriptional pr<strong>of</strong>ile with few<br />
shared genes in top networks or canonical pathways, although lipid metabolism was<br />
a function associated with all top networks. Distinct from the other groups,<br />
MMAIII exposure in UROtsa cells generated changes in several top molecular networks<br />
that are consistent with pathways suspected to play key roles in human UB<br />
carcinogenesis, suggesting that common factors may drive UB carcinogenesis in humans<br />
and that they may be distinct from those in rats. [This abstract does not necessarily<br />
reflect EPA policy.]<br />
2646 THE EFFECTS OF ORAL TREATMENT WITH<br />
TRANSFLUTHRIN ON THE BLADDER EPITHELIUM<br />
OF RATS AND MICE AND ITS METABOLITE,<br />
TETRAFLUOROBENZOIC ACID ON UROTHELIAL<br />
CELLS IN VITRO.<br />
S. M. Cohen 1 , L. Arnold 1 , S. Lautraite 2 , L. Sheets 2 , S. Wason 2 , B. Stahl 2 , D.<br />
Eigenberg 3 , K. L. Pennington 1 , S. Kakiuchi-Kiyota 1 and M. Yokohira 1 .<br />
1 University <strong>of</strong> Nebraska Medical Center, Omaha, NE, 2 Bayer AG, Bayer<br />
CropScience, Monheim, Germany and 3 Xenometrics, Stilwell, KS.<br />
Transfluthrin, a pyrethroid insecticide, induced urinary bladder tumors in rats but<br />
not in mice in 2-year bioassays. <strong>The</strong> mechanism was investigated via an in vivo<br />
study with transfluthrin in rats and mice and in vitro studies to examine the effects<br />
<strong>of</strong> its major metabolite tetrafluorobenzoic acid (TFBA) on rat (MYP3) and human<br />
(1T1) urothelial cell lines. For the in vivo study, rats were fed diet containing 0,<br />
2000 or 5000 ppm transfluthrin for 4 weeks, 0 or 2000 ppm for 13 weeks, or coadminstered<br />
1.25% NH4Cl with 0 or 5000 ppm transfluthrin to evaluate the effects<br />
<strong>of</strong> acidification <strong>of</strong> the urine. Mice were treated with 0 or 1000 ppm transfluthrin<br />
for 4 weeks. After 4 weeks, there was no evidence <strong>of</strong> hyperplasia or<br />
increased bromodeoxyuridine labeling index in any treatment group. After 13<br />
weeks treatment with 2000 ppm transfluthrin, cytotoxicity and necrosis <strong>of</strong> the<br />
urothelial superficial layer were detected in the rat bladder by scanning electron microscopy.<br />
<strong>The</strong> urinary concentration <strong>of</strong> TFBA in rats fed 2000 ppm transfluthrin<br />
was 2.94±0.67 mM. <strong>The</strong> LC50 <strong>of</strong> TFBA was 2.25 mM for MYP3 cells and 2.43<br />
mM for 1T1 cells. <strong>The</strong>se studies support cytotoxicity and regenerative proliferation<br />
as the mechanism for induction <strong>of</strong> bladder tumors with high oral doses <strong>of</strong> transfluthrin<br />
due to metabolism <strong>of</strong> transfluthrin to the weakly cytotoxic TFBA that is<br />
excreted at high concentrations in the urine <strong>of</strong> rats administered high doses <strong>of</strong><br />
transfluthrin (≥2000 ppm) for an extended period.<br />
2647 NEUROBEHAVIORAL ALTERATIONS IN CARG-BOX<br />
BINDING FACTOR-A KNOCK-OUT MICE.<br />
J. T. Barrett 1, 2 , J. R. Richardson 2 , X. Zhang 3 , M. Fang 2 , K. R. Reuhl 2, 4 and H.<br />
Zarbl 2 . 1 GSBS, UMDNJ, Piscataway, NJ, 2 EOHSI, RWJMS, UMDNJ, Piscataway,<br />
NJ, 3 University <strong>of</strong> Washington, Seattle, WA and 4 Rutgers, Piscataway, NJ.<br />
CArG-box binding factor A (CBF-A) is a member <strong>of</strong> the heterogeneous nuclear ribonucleoproteins<br />
(hnRNPs) family <strong>of</strong> RNA-binding proteins that are involved in a<br />
variety <strong>of</strong> cellular functions. We previously showed that deregulation <strong>of</strong> CBF-<br />
A/hnRNP A/B is involved in transcriptional regulation <strong>of</strong> the HA-ras promoter and<br />
contributes to mammary carcinogenesis. Recently, we have developed CBF-A<br />
knock-out mouse models to further study the functions <strong>of</strong> this hnRNP protein. In<br />
addition to its role in mammary carcinogenesis, CBF-A is also expressed in the<br />
brain and is involved in regulation <strong>of</strong> immediate early gene expression.<br />
Furthermore, a single nucleotide polymorphism (SNP) in the arginine vasopressin<br />
gene promoter that reduced CBF-A binding was associated with alterations in anxiety<br />
behavior. To directly determine the role <strong>of</strong> CBF-A in neurobehavior, we assessed<br />
open-field locomotor function and anxiety behavior in an elevated plus maze<br />
for wild type, heterozygous, and CBF-A null mice. For locomotor activity, mice<br />
were allowed to habituate to the open-field for 30 min and ambulatory distance<br />
and vertical counts were calculated over the next 30 min. For the elevated plus<br />
maze, mice were allowed to freely explore the maze for 5 min, and percent time<br />
spent in the open arms was determined. In both tasks, there were no significant differences<br />
between wild-type and mice heterozygous for CBF-A. However, ambulatory<br />
distance traveled was increased by 89% in CBF-A null mice compared to wildtype.<br />
CBF-A null mice also demonstrated a 230% increase in vertical activity. In<br />
the elevated plus maze, CBF-A null mice spent 319% more time in the open arms<br />
<strong>of</strong> the maze compared to wild-type, suggesting that loss <strong>of</strong> CBF-A results in a lowanxiety<br />
phenotype. Taken in concert, these data suggest that CBF-A plays an important<br />
role in neurobehavioral function. Supported by R01ES015991 and<br />
P30ES005022<br />
2648 INFLUENCE OF BENZO(A)PYRENE (BAP)<br />
BIOTRANSFORMATION ON BAP-INDUCED<br />
CYTOTOXICITY IN HT-29 HUMAN COLON CANCER<br />
CELLS.<br />
J. N. Myers and A. Ramesh. Biochemistry & Cancer Biology, Meharry Medical<br />
College, Nashville, TN.<br />
<strong>The</strong> majority <strong>of</strong> sporadic cancer deaths are attributed to exposure and intake <strong>of</strong> environmental<br />
toxicants. Benzo(a)pyrene (BaP) is one such ubiquitous environmental<br />
toxicant. Being a combustion byproduct, high levels <strong>of</strong> BaP have been detected in<br />
SOT 2011 ANNUAL MEETING 567